The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Perkins Adelene Q since year 2005.
The trader's CIK number is 1375124.
At the time of this reporting, Perkins Adelene Q is the Pres & Chief Business Officer of Infinity Pharmaceuticals, Inc. .
(stock ticker symbol INFI).
See this page for all insider trading activities at Infinity Pharmaceuticals, Inc. .
Stock purchases, sales, and option exercises reported by insider Perkins Adelene Q since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-11-24
INFI
Infinity Pharmaceuticals, Inc.
Purchase
21,941
6.09
133,524
2008-11-25
INFI
Infinity Pharmaceuticals, Inc.
Purchase
100
5.70
570
2008-03-17
INFI
Infinity Pharmaceuticals, Inc.
Purchase
776
5.91
4,588
2008-03-17
INFI
Infinity Pharmaceuticals, Inc.
Purchase
776
5.91
4,588
2007-06-15
INFI
Infinity Pharmaceuticals, Inc.
Purchase
10,000
10.64
106,383
2007-05-09
INFI
Infinity Pharmaceuticals, Inc.
Purchase
1,000
10.95
10,950
2007-05-10
INFI
Infinity Pharmaceuticals, Inc.
Purchase
2,500
10.83
27,075
2007-05-11
INFI
Infinity Pharmaceuticals, Inc.
Purchase
2,946
10.86
31,986
2007-05-03
INFI
Infinity Pharmaceuticals, Inc.
Purchase
900
11.24
10,120
2007-05-04
INFI
Infinity Pharmaceuticals, Inc.
Purchase
10,248
11.07
113,444
2007-05-07
INFI
Infinity Pharmaceuticals, Inc.
Purchase
4,000
10.89
43,565
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Perkins Adelene Q
(Pres & Chief Business Officer of Infinity Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
